i3 Success Stories

Success Stories: Driving Impact Across Pharma and Healthcare

Explore how our tailored strategies and expert insights have enabled clients to overcome challenges and achieve remarkable results in the life sciences and healthcare industries. From market entry roadmaps for parenteral drug therapies to orchestrated campaigns boosting HCP engagement, our solutions deliver measurable impact. Discover how we have optimized product launches, enhanced market intelligence, and refined pricing strategies, empowering businesses to thrive in competitive global markets.

Parenteral Drug Therapies: Processing and Packaging Expert

0-6 months | Grand Rapids, MI | Medium Enterprise

Project Type:   Go-to-Market Strategy | Industry Type: Pharma & Biotech | Business Unit: Analytics & Business Intelligence

Problem:   The client was seeking to break into the European market and needed a GTM roadmap for its product portfolio of processing and packaging materials for the parenteral drug therapy market.

Action:   Provided insights into the design and performance attributes for the transport of biologics (single-use bioreactor media containers), pre-fillable syringes, vials and cartridges, and DPTE transport bags (alpha/beta port bags) that are used within this value chain process.

Result:   The final deliverable was a GTM strategy report for European market access. For further details Click here for a scrubbed client sample to demonstrate the quality and capability in terms of reporting. 

Engagement of HCPs for a Major Respiratory Product

0-6 months | Bucharest, Bucharest | Large Enterprise

Project Type:   Marketing Strategy Project Management | Industry Type: Healthcare Services | Business Unit: Product Management

Problem:   A life science client company wanted to maximise its reach and engagement with key HCP customers for a major respiratory product across its overseas markets (non-US) with better efficiency, improvising on existing customer intelligence yet without raising its field force numbers.

Action:   Based on its existing intelligence, three key HCP segments were identified and engaged with through an orchestrated campaign covering email, paid media, portals and partner channels. An automated loop was also set up to progress key messaging based on HCP responses.

Result:   Through this orchestrated campaign and loop, we were able to increase its target audience reach by 32% and engagement by 62% over the course of 18 weeks.

Hypertension Product Manager

0-6 months | Remote | Large Enterprise

Project Type:   Marketing Strategy Project Management | Industry Type: Pharma & Biotech | Business Unit: Product Management

Problem:   Across a fragmented European market, a pharma client needed to increase the adoption of its mature hypertension product by improving the impact of its key messages.

Action:   Based on market analytics, a system of pre- and post-call medical rep-triggered events was created, enabling the reps to opt for further engagements and content according to the HCP type, appropriate key messages and outcome of the call.

Result:   This systematic approach, combined with leveraging of the client’s sales software, enabled automated content for follow-up email campaigns, which in turn increased email open rates among targeted HCPs by 37% and overall engagement by 65% over 12 weeks.

Improved KOL Engagement for Oncology Medicines

6-12 months | Remote | Small Enterprise

Project Type:   Market Research Project Management | Industry Type: Healthcare Services | Business Unit: Analytics & Business Intelligence

Problem:   A market research client needed to outsource a primary research project in therapy areas of T-cell prolymphocytic leukemia (PTCL), refractory PTCL, Hodgkin’s lymphoma and CD30+ lymphoma.

Action:   Conducted a year-long primary research project on T-cell prolymphocytic leukemia, refractory PTCL, Hodgkin’s lymphoma, and CD30+ lymphoma. Managed translations for interviews with KOLs in oncology and hematology across Chinese, Japanese, and Portuguese. Analyzed responses and delivered key findings in presentation decks to regional managers, supporting NME launch strategies in Australia, Brazil, China, and Japan.

Result:   Delivered actionable insights from a year-long primary research project on T-cell prolymphocytic leukemia, refractory PTCL, Hodgkin’s lymphoma, and CD30+ lymphoma. Findings supported NME launch strategies in Australia, Brazil, China, and Japan, enabling regional managers to make informed decisions, optimize market entry, and strengthen product positioning in these therapy areas.

Market Research for a SME Pharma Client

6-12 months | Remote | Small Enterprise

Project Type:   Market Research Project Management | Industry Type: Pharma & Biotech | Business Unit: Analytics & Business Intelligence

Problem:   The client needed market research to be conducted to support their pricing strategy for an anti-hypertension drug in late phase 3 clinical trials.

Action:   Developed a pricing strategy for a SME pharma company’s late-phase anti-hypertension drug using primary research (30 interviews with physicians and pharmacists) and secondary market analysis. Evaluated clinical value, competition, and reimbursement positioning across four countries.

Result:   Delivered a pricing model and strategy roadmap aligning price points with revenue goals, resulting in successful PRMA execution and surpassing launch revenue targets within a year.

Market Sizing of Paediatric Asthma Aspirator Space

0-6 months | Remote | Small Enterprise

Project Type:   Market Landscape | Industry Type: Healthcare Services | Business Unit: Analytics & Business Intelligence

Problem:   Medical device client needed a third-party opinion on the viable market size for its paediatric asthma aspirator.

Action:   Led a market sizing report for paediatric asthma aspirators using three methods: 1) leveraged research from Kalorama Information and Freedonia Group, 2) calculated use via sources like the US Census Bureau, Eurostat, and UN Comtrade using the formula Apparent Consumption = Domestic Production – Exports + Imports, and 3) conducted a supplier census targeting a concentrated base of fewer than 10 key producers.

Result:   Delivered a market sizing report for the paediatric asthma aspirator (PAA) market, combining insights from Kalorama Information and Freedonia Group with detailed consumption calculations and supplier analysis. The report identified market opportunities and risks, refining strategies for entry and partnerships. This work improved forecast accuracy by 15%, empowering stakeholders to make informed decisions and optimize resource allocation.

Analysing a Biotechnology Company for its Innovation, Strategy and Technological Value

0-6 months | London, England | Small Enterprise

Project Type:   Organizational Design & Assessment | Industry Type: Pharma & Biotech | Business Unit: Consulting & Advisory

Problem:   Our client was a university-based incubator company preparing for its IPO. In order to do this, they needed a comprehensive evaluation of the protein biomarker marketplace, including sales trends, competitive activity, client needs analysis and analogous case studies of competitors.

Action:   Analyzed a biotechnology client for Its innovation, strategy and technological value. Focus group meetings were set up from a cross-section of the client’s value chain to brainstorm on the critical success factors that will procure a greater market share. Full-scale value chain and cost reduction analyses were conducted to clearly identify the organizational and operational transformations necessary for maximizing the profit margin.

Result:   A full SWOT audit of the Biotech’s R&D, operational, technological and digital systems was conducted and reported for the client in a new business model road map. For further details Click here

(Source: A.T. Kearney analysis) Figure 1: Biotech Value Chain Analysis